These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 3822880)

  • 1. [Evaluation of the effect of new fluoroderivatives of piperazinol-quinoline on clinical strains of aerobic and anaerobic bacteria].
    Dzierzanowska D; Ukraiński W; Piotrowska E; Kazmirowska Z; Pykiel M
    Pol Tyg Lek; 1986 Sep; 41(37):1180-3. PubMed ID: 3822880
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of ciprofloxacin, norfloxacin, and ofloxacin against multi-resistant Enterobacteriaceae.
    Niculescu E; Wagener H
    Chemioterapia; 1987 Jun; 6(2 Suppl):132-3. PubMed ID: 3509369
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evolution of fluoroquinolone sensitivity in Staphylococcus aureus isolated from hemocultures in a general hospital].
    Cogollos R; Alós JI; Gómez-Garcés JL
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):460. PubMed ID: 8260521
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
    Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
    Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the in vitro susceptibility and emergence of mutants resistant to ciprofloxacin among multidrug resistant clinical isolates.
    Lopes CA; Mendes RP; Curi PC; Watanabe DS; Decarlis RM; Horácio A; Michelin LA; Placidelli BA
    Rev Latinoam Microbiol; 1993; 35(4):345-9. PubMed ID: 8066328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibility of bacteria isolated from clinical material to ciprofloxacin].
    Namysł E; Galiński J; Szponar M; Piechowicz L
    Med Dosw Mikrobiol; 1995; 47(1-2):5-9. PubMed ID: 8523970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro activity of the combination of daptomycin and metronidazole against Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus spp., and Bacteroides spp.
    Werner H; Nagy E; Heizmann WR
    J Chemother; 1989 Jul; 1(4 Suppl):207-8. PubMed ID: 16312371
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vitro antibacterial activity of ciprofloxacin against uropathogenic organisms].
    Allocati N; Catamo G; Cellini L
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1927-33. PubMed ID: 6440583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
    Michalska W; Chylak J; Pietkiewicz K
    Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo microbiological evaluations of cefoperazone.
    Renzini G; Ravagnan G; Piccolomini R; Dainelli B; Comanducci A
    Clin Ther; 1980; 3(Spec Issue):139-44. PubMed ID: 6446388
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
    Mirelis B; Navarro F; Miró E; Coll R; Xicota MA; Prats G
    Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on pyridonecarboxylic acids as antibacterial agents. XII. Synthesis and antibacterial activity of 6-chloro-1-cyclopropyl-7-(1-piperazinyl)-1, 4-dihydro-4-oxo-quinoline-3-carboxylic acid and analogues].
    Li XH; Tian ZM; Miao H; Yu LX; Guo HY
    Yao Xue Xue Bao; 1997 Nov; 32(11):844-51. PubMed ID: 11596203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro studies of tobramycin sensitivity of bacterial strains isolated from children treated in the Institute for Mother and Child].
    Duroś H; Nowakowska K
    Probl Med Wieku Rozwoj; 1982; 11():117-20. PubMed ID: 6817325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resistance phenotypes to 4 antibiotics of bacteria isolated in a hospital setting].
    Baaj AJ; Nejmi S; Mellouki W
    Maghrib Tibbi; 1981 Mar; 3(1):501-14. PubMed ID: 7345243
    [No Abstract]   [Full Text] [Related]  

  • 15. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the fluoroquinolone antibiotics.
    Just PM
    Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Doxycycline sensitivity in 80 hospital strains resistant to tetracycline].
    Bergogne-Berezin E; Berthelot G; Joly ML
    Nouv Presse Med; 1980 Jan; 9(21 Suppl):103-110. PubMed ID: 7355077
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical studies of norfloxacin in urinary tract infections].
    Matsuura T; Kurita T
    Hinyokika Kiyo; 1985 Nov; 31(11):2085-9. PubMed ID: 4091145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Actual germ spectrum in wound surgery].
    Ortel S
    Zentralbl Chir; 1982; 107(11):628-38. PubMed ID: 6812311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of fluoroquinolones against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Tripathi KD; Sharma AK; Valecha N; Biswas S
    Indian J Malariol; 1993 Jun; 30(2):67-73. PubMed ID: 8405596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.